Focus on Cedric Francois, MD, PhD, CEO, Apellis Pharmaceuticals
Retina Synthesis - Un pódcast de Retina Synthesis
Categorías:
Dr. Francois discusses the epidemiology of geographic atrophy, the pathophysiology of complement inhibition in the treatment of GA, and the latest information on Apellis' Phase 2 and Phase 3 clinical trials.
